All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.
The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
Infections associated with bispecific antibodies
Featured:
Paul Richardson
Elena Zamagni
Hermann Einsele
Heinz Ludwig
María-Victoria Mateos
Meral Beksaç
Vania Tietsche de Moraes HungriaDuring the Multiple Myeloma Hub Steering Committee Meeting in May 2024, leading experts met to discuss key considerations regarding infections associated with bispecific antibodies.
Infections associated with bispecific antibodies
Meral Beksaç opened with a presentation reviewing the infectious complications associated with bispecific antibodies and current treatment algorithms for such infections. Beksaç explored an analysis of infections and parameters of humoral immunity in the MonumenTAL-1 study, the clinical management of infections, and regional differences in access to prophylaxis and treatment for infections.
Infections associated with bispecific antibodies (Q&A)
Following her presentation, Beksaç chaired a Q&A session featuring Hermann Einsele, Heinz Ludwig, María-Victoria Mateos, Paul Richardson, Vania Tietsche de Moraes Hungria[JD1] [LN2] [JD3] , and Elena Zamagni[LN4] [JD5] [JD6] . Discussions included the challenges associated with COVID infections, the need for vaccination of donors for intravenous immunoglobulin treatment, and the impact of dosing schedules on reducing infectious complications and T‑cell exhaustion.
Infections associated with bispecific antibodies
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
